Bleach? Chloroquine and hydroxychloroquine (avoid those)? UV enemas? Nope, it's Gilead's Remdesivir. GILD shares are up afterhours.
FDA to authorize emergency use of new coronavirus treatment
By BY NATHANIEL WEIXEL at The Hill
Excerpt:
The Trump administration is fast-tracking authorization of the drug remdesivir as a treatment for COVID-19.
The Food and Drug Administration (FDA) on Friday announced the drug will receive an "emergency use authorization" after it showed promising results during a clinical trial.
Early results released this week showed the drug had modest success in reducing the time COVID-19 patients were in the hospital.
President Trump addressed the fast-track authorization during an Oval Office meeting with the CEO of Gilead, which developed the antiviral drug.
"It’s really a very promising situation," Trump said.
Gilead CEO Daniel O'Day said the drug is an "important first step" for hospitalized patients. The company will be donating about 1.5 million vials of the drug, and the federal government will determine how to distribute it…
Picture by BaptisteGrandGrand – Own work, CC BY-SA 4.0, Link
